The largest database of trusted experimental protocols

16 protocols using anti mlh1

1

Western Blot Analysis of MLH1 Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were lysed in a buffer containing 50 mM Tris-HCl (pH 7.5), 200 mM NaCl, 1% Tween-20, 0.2% NP-40, 2 mM PMSF, and 50 mM β-glycerophosphate and protease inhibitor cocktail tablet (Roche). 40μg of protein lysates were loaded into SDS-PAGE mini-gels (Bio-Rad). The gel was then transferred onto nitrocellulose membranes for 2 hours at 100mV. Anti-MLH1 (1:1000) (BD Pharmingen) and anti-β-ACTIN (1:10000) (Sigma Aldrich) antibodies were diluted in Intercept Blocking Buffer (LI-COR Biosciences) and incubated overnight at 4°C. Fluorescent secondary antibody anti-mouse IgG-AlexaFluor488 (LI-COR Biosciences) was diluted (1:10000) in Intercept Blocking Buffer and incubated for 1 hour at room temperature. Image acquisition was perfomed using a Odyssey Clx machine (LI-COR Biosciences).
+ Open protocol
+ Expand
2

Molecular Characterization of Right-Sided Colorectal Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary tumor location was determined by operative findings. Cancer in the cecum, ascending colon, hepatic flexure, or transverse colon was classified as right-sided; and cancer in the splenic flexure, descending colon, sigmoid colon, rectosigmoid, or rectum was classified as left-sided [29 (link), 30 (link)]. Histopathological features associated with RCRC, such as medullary type, mucinous type, signet ring type, and tumor-infiltrating lymphocytes were analyzed by a previously reported method [31 ]. MutL homologue 1 (MLH1)/MutS homologue 2 (MSH2) status was evaluated in 110 of the 201 patients by immunohistochemistry with anti-MLH1 (1:50; BD Biosciences PharMingen, San Diego, CA) and anti-MSH2 (1:50; Leica Microbiosystems, Tokyo, Japan) antibodies. Hypermutation was defined as a tumor with MSI-H and/or high tumor mutation burden (TMB), as described previously [25 (link)], using CGS. TMB was calculated as the number of non-synonymous mutations per megabase of sequence in the panel (panel size = 1.3 Mb). To be classified as hypermutated, the threshold of TMB was set as the lowest TMB observed in tumors with MSI-H. Tumors with mutations in POLE or other DNA repair genes can have very high TMB but not show MSI-H [25 (link)].
+ Open protocol
+ Expand
3

Immunohistochemical Evaluation of MMR Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemical (IHC) evaluation of MMR proteins expression was carried out on paraffin-embedded tissue sections of all tumors. The following mouse monoclonal antibodies were used: anti-MLH1, anti-MSH2 (PharMingen, San Diego, CA), and anti-MSH6 Transduction Laboratories, BD Biosciences, Brazil. For PMS2 protein, a rabbit monoclonal antibody was used (Ventana Roche Diagnostic, Italy). Immunostaining was executed by the avidin-biotin peroxidase technique; diaminobenzidine was used as a chromogen. Staining was carried out in NEX-ES Automatic Staining System, after counterstaining with Hematoxylin. Normal tissue and stromal cells or lymphocytes adjacent to the respective tumor were used as internal positive controls. Loss of MMR proteins expression was defined as complete absence of nuclear staining in tumor cells (but maintained in normal epithelial and stromal cells).
+ Open protocol
+ Expand
4

Immunodetection of Meiotic Proteins in Murine Spermatocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Testes from 8 week-mice were decapsulated and seminiferous tubules were fixed and processed for spermatocyte spreading by the drying-down technique previously described20 (link), or processed for squashing as previously reported21 (link). Spread spermatocytes and squashed seminiferous tubules slides were rinsed three times in PBS and blocked with 2% Bovine Serum Albumin (BSA) in PBS for 20 min at room temperature (RT). After blocking, slides were incubated overnight at 4 °C with anti-TCFL5 (Sigma), anti-SYCP3 (Cell Signalling), anti-SYCP1 (Abcam), anti-H1t (Cell Signalling), anti-γH2AX (Cell Signalling), anti-MLH1 (Pharmingen), anti-Pan-cadherin (Cell Signaling) and anti-Tubulin (Cell Signalling) primary antibodies. Then, slides were washed in PBS and incubated for 1 h at RT with their corresponding secondary antibodies against rabbit, mouse, and guinea pig IgGs conjugated with Alexa 555, Alexa 594, and Alexa 488 (Molecular Probes). For actin and flagellar mitochondria immunodetections Alexa 488 Phalloidin (Thermo Fisher) and Mitotracker Red CM-H 2 Xros (Thermo Fisher) were used, respectively. Finally, cells were stained with 1 μg/ml DAPI and mounted using ProLong Glass Antifade Mountant (Thermo Fisher Scientific). Images and stacks were taken in sCMOS camera on a Zeiss Axiovert microscope and analyzed using ImageJ (NIH) and Adobe Photoshop CS5.1 software.
+ Open protocol
+ Expand
5

Evaluating Mismatch Repair Deficiency

Check if the same lab product or an alternative is used in the 5 most similar protocols
We used the presence of MSI to assess the loss of function of mismatch repair gene activity. Immunohistochemistry (IHC) and/or Multiplex polymerase chain reaction method was used to evaluate the status of MSI. We conducted IHC analysis of MSH2, MSH6, PMS2, and MLH1 proteins with formalin-fixed paraffin-embedded tumor samples. After the tumor area adjacent to normal mucosa and/or lymphocytic infiltration was marked, 4 mm of paraffinized tissue was removed, and multiple tissue blocks were prepared. Finally, 4-µm thick sections were obtained for IHC following standard protocols. The mouse monoclonal antibodies used were anti-MSH2, anti-MSH6, anti-MLH1, and anti-PMS2 (BD Pharmingen). Tumors showing a proportion of stained nuclei higher than 10% were classified as staining positive; all others were regarded as negative (Figure 1).
MSI test was performed by multiplex polymerase chain reaction and analysis with a 3130×1 genetic analyzer. MSI testing of DNA samples was based on five dinucleotide markers (NR27, NR21, BAT26, BAT25, and NR24). Tumors that showed instability in ≥2/5 of markers tested were classified as a high MSI and 1/5 of markers were classified as low MSI. Tumors that showed instability in 0/5 of markers were designated as microsatellite stable (MSS) cancers. Only high MSI cases were considered MSI positive.
+ Open protocol
+ Expand
6

Protein Extraction and Western Blotting

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total protein was extracted using RIPA buffer and was then electrophoresed on SDS-PAGE. Western blotting was conducted with mouse monoclonal anti-E-cadherin (1:500; BD Bioscience), anti-MLH1 (1:500; Pharmingen) and anti-MSH2 (1:500; Merck) antibodies, as has been reported [24 (link)].
+ Open protocol
+ Expand
7

Quantitative Immunoblot Analysis of MMR Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Approximately one million cells for each cell line were lysed in 120 μL RIPA buffer in the presence of protease inhibitors. 25 μg of each cell lysate was run on an 8% SDS-PAGE gel and probed with anti-MLH1 (BD Pharmingen # 554073, 1:1000), anti-PMS2 (BD Pharmingen # 556415, 1:1000), and anti-actin (Santa Cruz Biotechnology # sc-8432, 1:1000) antibodies. Quantitation of MLH1 and PMS2 levels in variant expressing lines was carried out in comparison to MLH1 or PMS2 levels in WT cells after being normalized for protein loading using actin levels via ImageJ software.
+ Open protocol
+ Expand
8

Protein Expression and Immunoblotting

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were lysed in ice-cold lysis buffer containing Hepes 50 nM, pH 7.5, EDTA 1 mM, pH 7, NaCl 150 mM, Naf 100 mM, Na3VO4 1 mM, Triton X-100 1%, and Proteinase Inhibitor Cocktail. Cell lysates were migrated in 12% SDS-PAGE (Sodium Dodecyl Sulfate–PolyAcrylamide Gel Electrophoresis). The following primary antibodies were used: anti-RAD51 (1/1000), anti-BMI1 (#2830, Cell Signaling, 1/1000), anti-LIG4 (MA5-32775, Thermo, 1/1000), anti-ATR (sc1887, Santa Cruz, 1/1000), and anti-phospho-ATR (2853 s, Cell Signaling, 1/1000), anti-ERCC1 (sheep mAb, Gift from C. Lachaud (CRCM, Marseille), 1/1000), and anti-MLH1 (BD Biosciences, 1/1000). Detection of vinculin (V9131, Sigma, 1/2000) or GAPDH (Rabbit pAb, Cell Signaling, 1/5000) was used as loading control.
+ Open protocol
+ Expand
9

Immunohistochemical Analysis of Mismatch Repair Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemical (IHC) analysis of MSH2, MSH6, PMS2, and MLH1 proteins was performed as previously described [16 (link), 19 (link), 20 (link)]. Briefly, after the tumor area adjacent to normal mucosa and/or lymphocytic infiltration had been marked, the paraffinized tissue was removed and multiple tissue blocks were prepared. Finally, 4 μm-thick sections were obtained for IHC following standard protocols. The mouse monoclonal antibodies used were anti-MSH2, anti-MSH6, anti-MLH1, and anti-PMS2 (BD Pharmingen, CA, USA).
+ Open protocol
+ Expand
10

Western Blot Analysis of Protein Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blot analysis was performed as described [7 (link)]. Proteins were detected by the Odyssey 9120 Infrared Imaging System (Li-Cor Biosciences, Lincoln, Nebraska, USA). The antibodies used were anti-MGMT (Merck Millipore, Billerica, Massachusetts, USA), anti-HSP90, anti-beta-actin (Santa Cruz Biotechnology, Heidelberg, Germany), anti-MSH2 (Calbiochem, San Diego, CA, USA), anti-MSH6 (Transduction Laboratories, Lexington, KY, USA) and anti-MLH1 (BD Pharmingen, Heidelberg, Germany).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!